Shortcomings in the current treatment of epilepsy

Contemporary drug therapy fails to control epileptic seizures in some 30% of patients, resulting in the need to employ other measures when they appear practicable. A good deal of potentially relevant statistical detail is available regarding the outcomes of the available antiepileptic therapies, but its interpretation is sometimes difficult because of uncertainty about the types of epilepsy to which it applies, and because of deficiencies in knowledge of the natural histories of the various epileptic syndromes, if untreated. The actual shortcomings in the contemporary treatment of epilepsy appear to arise not only from the limited curative capacities of the available therapies, but from a number of deficiencies in knowledge concerning the significant aspects of what should determine treatment policy and the optimal employment of antiepileptic drugs.

[1]  D. Schmidt,et al.  The influence of seizure type on the efficacy of plasma concentrations of phenytoin, phenobarbital, and carbamazepine. , 1986, Archives of neurology.

[2]  E. Perucca,et al.  A multicenter, randomized, placebo‐controlled trial of levetiracetam in children and adolescents with newly diagnosed absence epilepsy , 2011, Epilepsia.

[3]  S. Spencer,et al.  Outcomes of epilepsy surgery in adults and children , 2008, The Lancet Neurology.

[4]  E. Beghi,et al.  Recurrence after a first unprovoked seizure. Is it still a controversial issue? , 1993, Seizure.

[5]  E. Brodtkorb,et al.  Second-generation antiepileptic drugs and pregnancy: a guide for clinicians , 2012, Expert review of neurotherapeutics.

[6]  M. Brodie.  Juvenile Myoclonic Epilepsy 25 Years After Seizure Onset: A Population-Based Study. , 2023, Neurology.

[7]  S. Sisodiya.  Mechanisms of antiepileptic drug resistance , 2003, Current opinion in neurology.

[8]  E. Beghi,et al.  Discontinuing antiepileptic drugs in patients who are seizure free on monotherapy , 2002, Journal of neurology, neurosurgery, and psychiatry.

[9]  Josemir W Sander.  The epidemiology of epilepsy revisited , 2003, Current opinion in neurology.

[10]  F. Andermann,et al.  Levetiracetam for the treatment of idiopathic generalized epilepsy with myoclonic seizures , 2008, Neurology.

[11]  D. Commenges,et al.  Long‐term prognosis in two forms of childhood epilepsy: Typical absence seizures and epilepsy with rolandic (centrotemporal) EEG foci , 1983, Annals of neurology.

[12]  J. Jackson,et al.  ON THE ANATOMICAL & PHYSIOLOGICAL LOCALISATION OF MOVEMENTS IN THE BRAIN. , 1873 .

[13]  S. Shorvon.  The treatment of chronic epilepsy: a review of recent studies of clinical efficacy and side effects. , 2007, Current opinion in neurology.

[14]  W Allen Hauser,et al.  Do seizures beget seizures? , 2002, Progress in brain research.

[15]  E. Reynolds,et al.  Controversies in Management: Do anticonvulsants alter the natural course of epilepsy? Treatment should be started as early as possible , 1995 .

[16]  Josemir W Sander,et al.  Some Aspects of Prognosis in the Epilepsies: A Review , 1993, Epilepsia.

[17]  M. Brodie,et al.  Diagnosing refractory epilepsy: response to sequential treatment schedules , 2006, European journal of neurology.

[18]  M. Eadie,et al.  Plasma Antiepileptic Drug Concentrations During Pregnancy , 1991, Epilepsia.

[19]  Shlomo Shinnar,et al.  Update on the Epidemiology and Prognosis of Pediatric Epilepsy , 2002, Journal of child neurology.

[20]  C. Sampaio,et al.  Clinical comparability of the new antiepileptic drugs in refractory partial epilepsy: A systematic review and meta‐analysis , 2011, Epilepsia.

[21]  A. Berg,et al.  The risk of seizure recurrence following a first unprovoked seizure , 1991, Neurology.

[22]  Y. M. Hart,et al.  Remission of epilepsy: results from the National General Practice Study of Epilepsy , 1995, The Lancet.

[23]  M. Eadie,et al.  Factors Influencing Simultaneous Concentrations of Carbamazepine and Its Epoxide in Plasma , 1981, Therapeutic drug monitoring.

[24]  John W. Scott,et al.  Selected Writings of John Hughlings Jackson , 1959 .

[25]  M. Brodie,et al.  Diagnosing and predicting refractory epilepsy , 2005, Acta neurologica Scandinavica. Supplementum.

[26]  M. Brodie,et al.  Combining antiepileptic drugs—Rational polytherapy? , 2011, Seizure.

[27]  Josemir W Sander,et al.  Factors predicting prognosis of epilepsy after presentation with seizures , 2000, Annals of neurology.

[28]  B. Bourgeois,et al.  Antiepileptic drugs—best practice guidelines for therapeutic drug monitoring: A position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies , 2008, Epilepsia.

[29]  E. Sieveking.  Analysis of Fifty-two Cases of Epilepsy observed by the Author. , 1857, Medico-chirurgical transactions.

[30]  A. Berg,et al.  Does Antiepileptic Drug Therapy Prevent the Development of “Chronic” Epilepsy? , 1996, Epilepsia.

[31]  M. Sillanpää,et al.  Is incident drug-resistance of childhood-onset epilepsy reversible? A long-term follow-up study. , 2012, Brain : a journal of neurology.

[32]  C L Rümke,et al.  [Incidence and prevalence]. , 1983, Nederlands tijdschrift voor geneeskunde.

[33]  T. Perkins.  Randomized clinical trial on the efficacy of antiepileptic drugs in reducing the risk of relapse after a first unprovoked tonic-clonic seizure: First Seizure Trial Group Neurology 43:478–483 March 1993 , 1993 .

[34]  M. Eadie.  Plasma Antiepileptic Drug Monitoring in a Neurological Practice: A 25‐Year Experience , 1994, Therapeutic drug monitoring.

[35]  M. Eadie,et al.  Maternal valproate dosage and foetal malformations , 2005, Acta neurologica Scandinavica.

[36]  S. Shorvon,et al.  Prognosis of chronic and newly diagnosed epilepsy: revisiting temporal aspects , 2007, Current opinion in neurology.

[37]  K. Meador,et al.  Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs. , 2009, The New England journal of medicine.

[38]  M. Yerby,et al.  Effects of Pregnancy on Antiepileptic Drug Utilization , 1985, Epilepsia.

[39]  C. Bearer.  Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register , 2007 .

[40]  First Seizure.  Randomized clinical trial on the efficacy of antiepileptic drugs in reducing the risk of relapse after a first unprovoked tonic‐clonic seizure , 1993, Neurology.

[41]  J. Jackson.  A STUDY OF CONVULSIONS , 1970 .

[42]  E. Beghi,et al.  Treatment of first tonic-clonic seizure does not improve the prognosis of epilepsy , 1997, Neurology.

[43]  art ecott.  The Diagnosis of Diseases of the Brain, Spinal Cord, Nerves, and Their Appendages , 1855, The British and Foreign Medico-Chirurgical Review.

[44]  J. Cross,et al.  The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial , 2008, The Lancet Neurology.

[45]  E KIORBOE.  The prognosis of epilepsy. , 1961, Acta psychiatrica Scandinavica. Supplementum.

[46]  S. Meadow,et al.  Congenital Abnormalities and Anticonvulsant Drugs , 1970, Proceedings of the Royal Society of Medicine.

[47]  M. Druet‐Cabanac,et al.  Epidemiology and aetiology of epilepsy in sub-Saharan Africa , 2005, The Lancet Neurology.

[48]  A. Berg,et al.  How Well Can Epilepsy Syndromes Be Identified at Diagnosis? A Reassessment 2 Years After Initial Diagnosis , 2000, Epilepsia.

[49]  Ettore Beghi,et al.  Efficacy and tolerability of the new antiepileptic drugs: comparison of two recent guidelines , 2004, The Lancet Neurology.

[50]  A. H. Knight,et al.  Epilepsy and Pregnancy: A Study of 153 Pregnancies in 59 Patients , 1975, Epilepsia.

[51]  R. Macdonald.  Cellular Actions of Antiepileptic Drugs , 1999 .

[52]  Dieter Schmidt,et al.  Modern antiepileptic drug development has failed to deliver: Ways out of the current dilemma , 2011, Epilepsia.

[53]  J. French,et al.  Refractory Epilepsy: Clinical Overview , 2007, Epilepsia.

[54]  W. J. Adie.  Pyknolepsy: A Form of Epilepsy occurring in Children, with a Good Prognosis , 1924 .

[55]  D. Goldstein,et al.  Association of multidrug resistance in epilepsy with a polymorphism in the drug-transporter gene ABCB1. , 2003, The New England journal of medicine.

[56]  P. Kwan,et al.  Early identification of refractory epilepsy. , 2000, The New England journal of medicine.

[57]  W. Hauser,et al.  The risk of epilepsy following febrile convulsions , 1979, Neurology.

[58]  Y. M. Hart,et al.  National General Practice Study of Epilepsy: recurrence after a first seizure , 1990, The Lancet.

[59]  P. Genton,et al.  Current limitations of antiepileptic drug therapy: a conference review , 2003, Epilepsy Research.

[60]  Gregory P. Lee,et al.  Effects of fetal antiepileptic drug exposure , 2012, Neurology.

[61]  C. Camfield,et al.  Does the number of seizures before treatment influence ease of control or remission of childhood epilepsy? Not if the number is 10 or less , 1996, Neurology.